Sam Altman invested $180 million into a company trying to delay death
When a startup called Retro Biosciences eased out of stealth mode in mid-2022, it announced it had secured $180 million
Read MoreWhen a startup called Retro Biosciences eased out of stealth mode in mid-2022, it announced it had secured $180 million
Read MoreA small biotech company claims it has used a technology called reprogramming to rejuvenate old mice and extend their lives,
Read More